The Blurred Thresholds of AI-Use Disclosure: Health Professions Education Journal Editors’ Expectations of Necessity and Sufficiency
Lorelei Lingard, Erik Driessen, Kevin Oswald
Bürokratie im Wandel der Worte: Verwendung des Bürokratie-Begriffs in parlamentarischen Debatten (1950–2023)
Jan Fivaz, Daniel Schwarz, Laurence Brandenberger, Sophia Schlosser, Thomas Gees, Christian Geiger
Erhöhung der lokalen Handlungsfähigkeit durch Datengenossenschaften – Transformation von Gemeinden in regionalen Verbänden
Christian Schachtner, Nadine Baumann
Generic Geonyms: Exploring Wikidata for Crosslinguistic Prototypical Semantics
Giuseppe Samo, Francesco-Alessio Ursini
pylimer-tools: A Python Package for Generating and Analyzing Bead-Spring Polymer Networks
Tim Bernhard, Fabian Schwarz, Andrei A. Gusev
Institutional Policy Pathways for Supporting Research Software: Global Trends and Local Practices
Michelle Barker, Jeremy Cohen, Pedro Hernández Serrano, Daniel S. Katz, Kim Martin, Dan Rudmann, Hugh Shanahan
Improving the Reliability of the Pavlovian Go/No-Go Task for Computational Psychiatry Research
Samuel Zorowitz, Gili Karni, Natalie Paredes, Nathaniel Daw, Yael Niv
Patent rights in a duopoly with price leadership
Jacek Prokop
Društveno Korisno Učenje kao Transformativna Paradigma za Unaprjeđenje Otpornosti i Kontinuiteta Humanitarnih Sustava / Service Learning as a Transformative Paradigm for Improving the Resilience and Continuity of Humanitarian Systems
Dora Naletina, Ante Vuletić, Kristina Petljak
Changes in bioelectrical and non-bioelectrical variables associated with overweight after a weight-loss program based on intestinal microbiota modulation
L. O. Tapasco-Tapasco, C. A. Gonzalez-Correa, P. A. Gomez-Buitrago
Investigation of an association between in vitro expression of TMEM154 and PARP14 genes and restriction of SRLV infection in primary skin cells of Carpathian goats
Magdalena Materniak-Kornas, Marlena Smagacz, Katarzyna Ropka-Molik, Aldona Kawęcka, Jacek Sikora, Jacek Michał Kuźmak
Gastrointestinal risk profile of tigecycline, omadacycline and eravacycline: Evidence from the FDA adverse event reporting system
Zhu Wang, Guoping Gan, Haiping Yao